3 completed, 1 withdrawn. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Aminopterin: new trials by email Literature Review of Aminopterin trials Research Report on Aminopterin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Aminopterin Pharmacokinetic Study In Moderate to Severe Psoriasis Aminopterin - Psoriasis | Phase 1 | Completed | Syntrix Biosystems, Inc. | 22 | 2009-06-01 | 2019-09-20 |
| CINJALL: Treatment for Children With Acute Lymphocytic Leukemia aminopterin, L-asparaginase, cyclophosphamide - Acute Lymphocytic Leukemia | Phase 2 | Completed | Rutgers, The State University of New Jersey | 60 | 2001-02-01 | 2014-06-09 |
| Aminopterin in Treating Patients With Recurrent or Refractory Endometrial Cancer aminopterin - Endometrial Cancer | Phase 2 | Withdrawn | Genzyme, a Sanofi Company | 1998-01-01 | 2018-09-18 | |
| Aminopterin in Treating Patients With Refractory Leukemia aminopterin, leucovorin calcium - Leukemia | Phase 2 | Completed | Genzyme, a Sanofi Company | 75 | 1997-07-01 | 2014-01-06 |
Leukemia (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Autoimmune Diseases (1) · Endometrial Neoplasms (1) · Leukemia, Myeloid, Acute (1) · Psoriasis (1)
Genzyme, a Sanofi Company (2) · Rutgers, The State University of New Jersey (1) · Syntrix Biosystems, Inc. (1)
United States (4)
Alan Menter, M.D. (1) · Barton A. Kamen, MD, PhD (1) · Barton Kamen, MD (1) · David S. Miller, MD (1)
P30CA072720 (1)